13C-Glucose Tracing of Tumour and T Cells in the Ascites of Ovarian Cancer Patients.

Recruiting Observational Study
Ovarian Cancer Ascites
No Placebo Group Every participant receives an active treatment — no one gets a placebo. No Study Drug Researchers observe your health over time — no experimental treatment is given.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 and older
Sex
Female
Study type
Observational
Participants needed
10 (estimated)
Sponsor
British Columbia Cancer Agency · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial

The objective of the study is to investigate the metabolism of cells in the ascites tumour microenvironment of ovarian cancer patients. This observational study involves intravenous infusion of \[U-13C\]glucose into patients during standard paracentesis.

Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * Ovarian cancer * Any stage or grade of disease * Ascites fluid that requires draining * Any treatment regimen * Primary or recurrent ascites * Understands the concept of the study and give informed consent. Exclusion Criteria: * Participants must not have diabetes or abnorma…
Contacts

Julian J. Lum, PhD

250-519-5700

JLum@bccancer.bc.ca

CONTACT

Jennifer Rauw, MD

250-519-5500

Jennifer.Rauw@bccancer.bc.ca

CONTACT